Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2025 Earnings Call Transcript July 31, 2025
Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $-0.34.
Operator: Good day, everyone, and thank you for standing by. My name is Argee, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2025 Vanda Pharmaceuticals, Inc. Earnings Conference Call. [Operator Instructions] I would now like to turn the...
